• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [23539 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2010     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Amifampridine (Firdapse) for the treatment of Lambert Eaton Myasthenic Syndrome]
2010     NIHR Horizon Scanning Centre (NIHR HSC) Tobramycin inhaled powder (TIP) for Pseudomonas aeruginosa infection in cystic fibrosis
2010     Andalusian Health Technology Assessment Area (AETSA) [Utility of 90Y-Ibritumomab Tiuxetan (Zevalin) in the treatment of adult patients with non-Hodgkin lymphoma]
2010     Health Council of the Netherlands Gezondheidsraad (GR) Fitness to drive. Proposal for some changes in the Regeling eisen geschiktheid 2000
2010     NIHR Horizon Scanning Centre (NIHR HSC) Ruxolitinib for myelofibrosis - first line
2010     Blue Cross Blue Shield Association (BCBS) Proton beam therapy for prostate cancer
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Atypical antipsychotics for the treatment of schizophrenia: a review of combination therapy and high-dosing strategies
2010     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Azacitidine (Vidaza) for the treatment of myelodysplastic syndromes]
2010     NIHR Horizon Scanning Centre (NIHR HSC) Zibotentan for metastatic castration resistant prostate cancer - first line
2010     Andalusian Health Technology Assessment Area (AETSA) [Vaccine for the prevention of Alzheimer's disease]
2010     Adelaide Health Technology Assessment (AHTA) Unattended sleep studies in the diagnosis and reassessment of obstructive sleep apnoea
2010     NIHR Horizon Scanning Centre (NIHR HSC) Taspoglutide for type 2 diabetes mellitus - add-on therapy
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Tramadol compared with opioids for pain: a review of addiction potential
2010     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [New-onset diabetes and antihypertensive treatment]
2010     NIHR Horizon Scanning Centre (NIHR HSC) Asenapine (Saphris) for manic episodes associated with bipolar l disorder
2010     Health Council of the Netherlands Gezondheidsraad (GR) Fitness to drive. Proposal for some changes in the Regeling eisen geschiktheid 2000
2010     NIHR Horizon Scanning Centre (NIHR HSC) Trastuzumab (Herceptin) for HER2 positive early, locally advanced and inflammatory breast cancer - neoadjuvant treatment
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Percutaneous heart valve replacement for valvular heart disease: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2010     NIHR Horizon Scanning Centre (NIHR HSC) Asenapine (Saphris) for schizophrenia
2010     NIHR Horizon Scanning Centre (NIHR HSC) Vorapaxar for acute coronary syndrome
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Cognitive behavioural therapy for post traumatic stress disorder: a review of the clinical and cost-effectiveness
2010     NIHR Health Technology Assessment programme Cost-effectiveness of screening high-risk HIV-positive men who have sex with men (MSM) and HIV-positive women for anal cancer
2010     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Invasive home mechanical ventilation, mainly focused on neuromuscular disorders]
2010     Medical Advisory Secretariat (MAS) Extracorporeal lung support technologies - bridge to recovery and bridge to lung transplantation in adult patients: an evidence-based analysis
2010     NIHR Horizon Scanning Centre (NIHR HSC) Dapagliflozin (BMS 512148) for type 2 diabetes mellitus - add on therapy
2010     NIHR Horizon Scanning Centre (NIHR HSC) Vorapaxar for secondary prevention of cardiovascular events
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Rituximab for non-hodgkin's lymphoma: a review of the clinical and cost- effectiveness and guidelines
2010     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [The importance of growth factors for the treatment of chronic wounds in the case of diabetic foot ulcers]
2010     Medical Advisory Secretariat (MAS) Solid organ transplantation for End Stage Organ Failure (ESOF) in persons with HIV
2010     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Galsulfase (Naglazyme) for the treatment of mucopolysaccharidosis type VI]
2010     NIHR Horizon Scanning Centre (NIHR HSC) Lapatinib plus paclitaxel for metastatic breast cancer - first line
2010     Andalusian Health Technology Assessment Area (AETSA) [Tool for the assessment of drugs for the treatment of inborn errors of metabolism. Anderson- Fabry disease]
2010     NIHR Horizon Scanning Centre (NIHR HSC) Zoledronic acid (Zometa) for hormone-receptor-positive early breast cancer - adjuvant therapy
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Use of antipsychotics and/or benzodiazepines as rapid tranquilization in inpatients of mental facilities and emergency departments: a review of the clinical effectiveness and guidelines
2010     NIHR Health Technology Assessment programme Sorafenib for the treatment of advanced hepatocellular carcinoma
2010     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Medical and health economic evaluation of prevention- and control measures related to MRSA infections or -colonisations at hospitals]
2010     Medical Advisory Secretariat (MAS) Endovascular laser treatment for varicose veins
2010     NIHR Horizon Scanning Centre (NIHR HSC) Rivaroxaban (Xarelto) for venous thromboembolism
2010     Andalusian Health Technology Assessment Area (AETSA) [Confocal microscopy in ophthalmology: Report summary of emergent technology]
2010     NIHR Horizon Scanning Centre (NIHR HSC) Conestat alfa (Ruconest) for acute hereditary angioedema
2010     NIHR Health Technology Assessment programme Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B infection
2010     Medical Advisory Secretariat (MAS) CT and MRI scans in the evaluation of chronic headaches
2010     NIHR Horizon Scanning Centre (NIHR HSC) Sunitinib for advanced and/or metastatic pancreatic neuroendocrine tumours
2010     NIHR Horizon Scanning Centre (NIHR HSC) Abiraterone acetate for metastatic, castration-resistant prostate cancer
2010     NIHR Health Technology Assessment programme Prasugrel for the treatment of acute coronary artery syndromes with percutaneous coronary intervention
2010     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in Germany]
2010     Medical Advisory Secretariat (MAS) Cancer screening with digital mammography for women at average risk of breast cancer or MRI for women at high risk
2010     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Plerixafor (Mozobil) in patients with lymphoma and multiple myeloma]
2010     NIHR Horizon Scanning Centre (NIHR HSC) Ustekinumab (Stelara) for psoriatic arthritis - second line after disease modifying anti-rheumatic drugs (DMARDs)
2010     NIHR Horizon Scanning Centre (NIHR HSC) AIN457 for Behcet's related uveitis - second line
2010     NIHR Health Technology Assessment programme Alitretinoin for the treatment of severe chronic hand eczema
2010     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Treatment of early-stage breast cancer by conservative surgery and intracavitary balloon brachytherapy]
2010     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Romiplostim (Nplate) and eltrombopag (Revolade) for the treatment of immune thrombocytopenic purpura]
2010     NIHR Horizon Scanning Centre (NIHR HSC) Vorinostat for refractory multiple myeloma
2010     Andalusian Health Technology Assessment Area (AETSA) [Tool for the assessment of drugs for the treatment of inborn errors of metabolism. Gaucher disease]
2010     Health Council of the Netherlands Gezondheidsraad (GR) [Vaccination of pregnant women against seasonal influenza 2010-2011]
2010     NIHR Horizon Scanning Centre (NIHR HSC) B-cell lymphoma vaccine (BiovaxID) for follicular non-Hodgkin's lymphoma
2010     NIHR Health Technology Assessment programme Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancer
2010     HAYES, Inc. AtriCure devices (AtriCure Inc.) for the thoracoscopic maze procedure
2010     Andalusian Health Technology Assessment Area (AETSA) [4D Ultrasound]
2010     Health Council of the Netherlands Gezondheidsraad (GR) Human vaccination against Q fever
2010     NIHR Horizon Scanning Centre (NIHR HSC) Boceprevir for hepatitis C
2010     NIHR Health Technology Assessment programme Topotecan for the treatment of recurrent and stage IVB carcinoma of the cervix
2010     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Laser treatment for benign prostatic hyperplasia. Proposal of assessment indicators]
2010     HAYES, Inc. Arthroscopic hip surgery for femoroacetabular impingement (FAI)
2010     Health Council of the Netherlands Gezondheidsraad (GR) Doping in unorganised sports
2010     NIHR Horizon Scanning Centre (NIHR HSC) Bosutinib for chronic myeloid leukaemia - first/second line
2010     NIHR Health Technology Assessment programme Trabectedin for the treatment of advanced metastatic soft tissue sarcoma
2010     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Information resources: developing user guides]
2010     HAYES, Inc. Avastin (Bevacizumab) (Genentech Inc.) for the treatment of metastatic renal cell carcinoma
2010     Health Council of the Netherlands Gezondheidsraad (GR) [Vaccination of infants against pneumococcal infections (2)]
2010     NIHR Horizon Scanning Centre (NIHR HSC) Botulinum toxin type A (Botox) for chronic migraine
2010     NIHR Health Technology Assessment programme Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia
2010     NIHR Health Technology Assessment programme Randomised controlled trials for policy interventions: a review of reviews and meta-regression
2010     HAYES, Inc. Avastin (Intravitreal Bevacizumab) (Genentech Inc.) for treatment of choroidal neovascularization secondary to pathological myopia
2010     Medical Advisory Secretariat (MAS) Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analaysis
2010     Health Council of the Netherlands Gezondheidsraad (GR) Neonatal screening for cystic fibrosis
2010     NIHR Horizon Scanning Centre (NIHR HSC) Iniparib for triple negative metastatic breast cancer - first, second or third line
2010     Technology Assessment at SickKids (TASK) Health technology assessment of thiopurine methyltransferase testing for guiding 6-mercaptopurine doses in pediatric patients with acute lymphoblastic leukemia
2010     HAYES, Inc. C-Leg Prosthesis (Otto Bock HealthCare LP)
2010     NIHR Horizon Scanning Centre (NIHR HSC) Canakinumab (Ilaris) for treatment of acute gout flares
2010     National Institute for Health and Care Excellence (NICE) Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events. NICE technology appraisal guidance 210
2010     Technology Assessment at SickKids (TASK) The use of biologic response modifiers in polyarticular-course juvenile idiopathic arthritis
2010     HAYES, Inc. Eovist (Bayer Schering Pharma AG) contrast agent for magnetic resonance imaging of the liver
2010     NIHR Horizon Scanning Centre (NIHR HSC) Canakinumab for systemic juvenile idiopathic arthritis
2010     National Institute for Health and Care Excellence (NICE) Prucalopride for the treatment of chronic constipation in women. NICE technology appraisal guidance 211
2010     Medical Advisory Secretariat (MAS) The relative cost-effectiveness of five non-invasive cardiac imaging technologies for diagnosing coronary artery disease in Ontario
2010     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Clinical practice guideline on acute bronchiolitis]
2010     HAYES, Inc. Ex-PRESS mini glaucoma shunt (Optonol Ltd., Neve Ilan, Israel)
2010     NIHR Horizon Scanning Centre (NIHR HSC) Eicosapentaenoic acid for familial adenomatous polyposis
2010     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Population ultrasound screening for abdominal aortic aneurysms]
2010     Institute of Health Economics (IHE) Evidence on the effectiveness of telerehabilitation applications
2010     National Institute for Health and Care Excellence (NICE) Bevacizumab in combination with oxaliplatin and either fluorouracil plus folinic acid or capecitabine for the treatment of metastatic colorectal cancer. NICE technology appraisal guidance 212
2010     Medical Advisory Secretariat (MAS) Use of contrast agents with echocardiography in patients with suboptimal echocardiography
2010     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Clinical practice guideline for attention deficit hyperactivity disorder (ADHD) in children and adolescents]
2010     HAYES, Inc. FIBROSpect II test (Prometheus Laboratories Inc.) for diagnosis of liver fibrosis in patients with hepatitis c
2010     Health Council of the Netherlands Gezondheidsraad (GR) For fat and thin. Prevention of overweight and obesity and the risk of eating disorders
2010     NIHR Horizon Scanning Centre (NIHR HSC) Fampridine-PR for multiple sclerosis: impaired mobility - first line
2010     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Cost-benefits evaluation of prevention and control of nosocomial MRSA infections]
2010     National Institute for Health and Care Excellence (NICE) Trastuzumab for the treatment of HER2-positive metastatic gastric cancer. NICE technology appraisal guidance 208